Net Cash Provided by (Used in) Operating Activities |
1.39M |
USD |
-46.9% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-488K |
USD |
-921% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-439K |
USD |
+81.4% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q1 2025 |
Q3 2025 |
Common Stock, Shares, Issued |
3.13M |
shares |
0% |
Q1 2025 |
Q3 2025 |
Common Stock, Par or Stated Value Per Share |
0.33 |
USD/shares |
0% |
Q1 2025 |
Q3 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
316K |
USD |
|
Q3 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
13.9M |
USD |
+149% |
Q1 2025 |
Q3 2025 |
Deferred Tax Assets, Gross |
4.23M |
USD |
0% |
Q1 2025 |
Q3 2025 |
Depreciation |
109K |
USD |
-8.39% |
Q3 2024 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
664K |
USD |
-70.2% |
Q3 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
7.11M |
USD |
+47.3% |
Q1 2025 |
Q3 2025 |
Property, Plant and Equipment, Gross |
2.54M |
USD |
+578% |
Q1 2025 |
Q3 2025 |
Deferred Income Tax Expense (Benefit) |
43.8K |
USD |
|
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
888K |
USD |
|
Q1 2024 |
Q3 2024 |
Share-based Payment Arrangement, Expense |
363K |
USD |
+35.1% |
Q1 2025 |
Q3 2025 |